Showing results (101-110 of 214) with videos related to
Sort By:
Pageof 22
Journal of Leukocyte Biology|August 1, 2002
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokinesGraham M Lord, Giuseppe Matarese, Jane K Howard, et al.The Journal of Experimental Medicine|April 15, 2021
The pleiotropic roles of leptin in metabolism, immunity, and cancerPaola de Candia, Francesco Prattichizzo, Silvia Garavelli, et al.FEBS Letters|June 27, 2017
Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesiclesPaola de Candia, Veronica De Rosa, Vincenzo Gigantino, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in miceElizabeth Papathanassoglou, Karim El-Haschimi, Xian Chang Li, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2013
Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosusYiyun Yu, Yaoyang Liu, Fu-Dong Shi, et al.Clinical Immunology (Orlando, Fla.)|November 23, 2013
Leptin promotes lupus T-cell autoimmunityGil Amarilyo, Noriko Iikuni, Fu-Dong Shi, et al.International Journal of Environmental Research and Public Health|March 19, 2020
Participation to Leisure Activities and Well-Being in a Group of Residents of Naples-Italy: The Role of ResilienceSergio Cocozza, Pier Luigi Sacco, Giuseppe Matarese, et al.Clinical Immunology (Orlando, Fla.)|February 19, 2026
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatmentClaudia Russo, Clorinda Fusco, Fortunata Carbone, et al.Glia|April 28, 2016
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitisAntonella Casamassa, Claudia La Rocca, Sophie Sokolow, et al.Pharmacological Research|November 30, 2011
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in miceAnna Maria Malfitano, Chiara Laezza, Mario Galgani, et al.Pageof 22